DK1694319T3 - Anvendelser af 4-hydroxytamoxifen til fremstilling af et medikament til behandling af gynækomasti - Google Patents
Anvendelser af 4-hydroxytamoxifen til fremstilling af et medikament til behandling af gynækomastiInfo
- Publication number
- DK1694319T3 DK1694319T3 DK04803913T DK04803913T DK1694319T3 DK 1694319 T3 DK1694319 T3 DK 1694319T3 DK 04803913 T DK04803913 T DK 04803913T DK 04803913 T DK04803913 T DK 04803913T DK 1694319 T3 DK1694319 T3 DK 1694319T3
- Authority
- DK
- Denmark
- Prior art keywords
- gynecomastia
- hydroxy tamoxifen
- patients
- patient
- hydroxytamoxifene
- Prior art date
Links
- 201000000079 gynecomastia Diseases 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- DODQJNMQWMSYGS-QPLCGJKRSA-N 4-[(z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-phenylbut-1-en-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 DODQJNMQWMSYGS-QPLCGJKRSA-N 0.000 abstract 3
- 230000001833 anti-estrogenic effect Effects 0.000 abstract 2
- 210000000481 breast Anatomy 0.000 abstract 2
- 230000035755 proliferation Effects 0.000 abstract 2
- 239000003098 androgen Substances 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 206010020718 hyperplasia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Reproductive Health (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/734,640 US7786172B2 (en) | 2002-12-18 | 2003-12-15 | Treatment of mastalgia with 4-hydroxy tamoxifen |
| EP03293156A EP1550440A1 (en) | 2003-12-15 | 2003-12-15 | Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia |
| PCT/EP2004/014295 WO2005058297A1 (en) | 2003-12-15 | 2004-12-13 | Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1694319T3 true DK1694319T3 (da) | 2008-11-17 |
Family
ID=34702366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04803913T DK1694319T3 (da) | 2003-12-15 | 2004-12-13 | Anvendelser af 4-hydroxytamoxifen til fremstilling af et medikament til behandling af gynækomasti |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1694319B1 (da) |
| JP (1) | JP5069469B2 (da) |
| AT (1) | ATE401067T1 (da) |
| AU (1) | AU2004298349B2 (da) |
| CA (1) | CA2549824C (da) |
| DE (1) | DE602004015146D1 (da) |
| DK (1) | DK1694319T3 (da) |
| ES (1) | ES2310765T3 (da) |
| MX (1) | MXPA06006834A (da) |
| NO (1) | NO336463B1 (da) |
| NZ (1) | NZ547744A (da) |
| PL (1) | PL1694319T3 (da) |
| PT (1) | PT1694319E (da) |
| WO (1) | WO2005058297A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1748770B1 (en) * | 2004-03-22 | 2008-04-09 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US20050208139A1 (en) * | 2004-03-22 | 2005-09-22 | Ascend Therapeutics, Inc. | Chemically stable compositions of 4-hydroxy tamoxifen |
| DK1799201T3 (da) * | 2004-10-14 | 2009-03-30 | Besins Int Lab | 4-Hydroxy-tamoxifen gelformuleringer |
| RU2373977C1 (ru) * | 2008-08-05 | 2009-11-27 | Государственное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей Федерального агентства по здравоохранению и социальному развитию" | Способ лечения болевого синдрома при викарном увеличении яичника после односторонней аднексэктомии |
| GB2608397B (en) * | 2021-06-29 | 2025-04-09 | Chaitowitz Ilan | Gynecomastia treatment |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2558373B1 (fr) * | 1984-01-20 | 1987-07-03 | Mauvais Jarvis Pierre | Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee |
| IL120268A0 (en) * | 1996-02-28 | 1997-06-10 | Pfizer | Use of (E)-1-[4'-(2-alkylaminoethioxy)phenyl]1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions |
| US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| ES2233570T3 (es) * | 2000-11-30 | 2005-06-16 | Pfizer Products Inc. | Composicion que contiene agonistas/antagosnistas de estrogenos y testosterona para tratar un descenso en el nivel de la hormona testosterona. |
| CA2448235A1 (en) * | 2001-07-31 | 2003-02-13 | Pfizer Products Inc. | Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| DK1317921T3 (da) * | 2001-12-07 | 2009-12-21 | Besins Mfg Belgium | Farmaceutisk sammensætning i form af en gel eller oplösning med dihydrotestosteron, fremgangsmåde til fremstilling og anvendelser heraf |
| NZ544031A (en) * | 2003-06-09 | 2008-08-29 | Univ Northwestern | Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen |
-
2004
- 2004-12-13 JP JP2006543519A patent/JP5069469B2/ja not_active Expired - Lifetime
- 2004-12-13 EP EP04803913A patent/EP1694319B1/en not_active Expired - Lifetime
- 2004-12-13 AU AU2004298349A patent/AU2004298349B2/en not_active Expired
- 2004-12-13 DE DE602004015146T patent/DE602004015146D1/de not_active Expired - Lifetime
- 2004-12-13 ES ES04803913T patent/ES2310765T3/es not_active Expired - Lifetime
- 2004-12-13 WO PCT/EP2004/014295 patent/WO2005058297A1/en not_active Ceased
- 2004-12-13 AT AT04803913T patent/ATE401067T1/de active
- 2004-12-13 PL PL04803913T patent/PL1694319T3/pl unknown
- 2004-12-13 CA CA2549824A patent/CA2549824C/en not_active Expired - Lifetime
- 2004-12-13 DK DK04803913T patent/DK1694319T3/da active
- 2004-12-13 PT PT04803913T patent/PT1694319E/pt unknown
- 2004-12-13 NZ NZ547744A patent/NZ547744A/en not_active IP Right Cessation
- 2004-12-13 MX MXPA06006834A patent/MXPA06006834A/es active IP Right Grant
-
2006
- 2006-06-21 NO NO20062904A patent/NO336463B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007529420A (ja) | 2007-10-25 |
| NO336463B1 (no) | 2015-08-31 |
| PT1694319E (pt) | 2008-10-24 |
| AU2004298349A1 (en) | 2005-06-30 |
| AU2004298349B2 (en) | 2010-02-25 |
| JP5069469B2 (ja) | 2012-11-07 |
| PL1694319T3 (pl) | 2009-01-30 |
| HK1094768A1 (en) | 2007-04-13 |
| ES2310765T3 (es) | 2009-01-16 |
| CA2549824C (en) | 2012-03-13 |
| CA2549824A1 (en) | 2005-06-30 |
| EP1694319A1 (en) | 2006-08-30 |
| MXPA06006834A (es) | 2006-09-04 |
| ATE401067T1 (de) | 2008-08-15 |
| DE602004015146D1 (de) | 2008-08-28 |
| NO20062904L (no) | 2006-06-21 |
| WO2005058297A1 (en) | 2005-06-30 |
| NZ547744A (en) | 2009-09-25 |
| EP1694319B1 (en) | 2008-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05010597A (es) | Prevencion y tratamiento de cancer de mama con tamoxifen 4-hidroxi. | |
| Cohen et al. | Lymphedema: strategies for management | |
| SG170730A1 (en) | Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 | |
| EA201000914A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
| BRPI0418745A (pt) | anticorpo linhagem de células, composição farmacêutica, e, método de tratamento de cáncer em um paciente | |
| EA200971053A1 (ru) | Способы лечения кожных язв | |
| Di Chiacchio et al. | Nail abrasion | |
| EA200601777A1 (ru) | Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии | |
| MX2009003532A (es) | Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina. | |
| SE0300098D0 (sv) | Use of cyclin D1 inhibitors | |
| DE60320398D1 (de) | Methoden und medizinische zusammensetzungen zur intravesikalen behandlung von blasenkrebs | |
| PT1631275E (pt) | Tratamento e prevenção da cicatrização excessiva com 4-hidroxi-tamoxifeno | |
| NO20062904L (no) | Anvendelse av 4-hydroksy tamoxifen for fremstilling av et medikament for behandling av gynekomasti | |
| de la Peña et al. | Subfascial gluteal augmentation | |
| EA201270298A1 (ru) | Способ лечения злокачественной опухоли | |
| DK1638492T3 (da) | Præoperativ behandling af postoperativ smerte | |
| ATE391499T1 (de) | 4-hydroxytamoxifen zur behandlung und prophylaxe von benignen brusterkrankungen | |
| JOP20200046A1 (ar) | طرق لعلاج أمراض مرتبطة بـtnf? | |
| US20120271216A1 (en) | Surgical pin compressive wound dressing housing | |
| ATE458819T1 (de) | Konjugat mit p21-protein zur krebsbehandlung | |
| DK1778834T5 (da) | Fremgangsmåder til anvendelse af regenerative celler i behandlingen af renale sygdomme og lidelser | |
| Ain et al. | Health Effects of a Wearable Multipolar Magnetic Field Device: Results of a Prospective, Double-blind, Randomized, Placebo-controlled Crossover Trial with Retail Workers Suffering from Chronic Musculoskeletal Pain | |
| BR112012013719A2 (pt) | uso de transferrina no tratamento de ß-talassemias | |
| RU39817U1 (ru) | Устройство для рефлексотерапии | |
| Close | Microfine glove and toe caps and their use in lymphoedema management |